Matthew Bieniosek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Matthew Bieniosek has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aaron T. Mayer
Enable Medicine, Menlo Park, USA
1 shared publication - Ahmad Makky
Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany
1 shared publication - Alexandro E. Trevino
Enable Medicine, Menlo Park, USA
1 shared publication Arjun Raman
Duchossois Family Institute, University of Chicago, Chicago, IL, 60637, USA
1 shared publicationChristian M. Schürch
Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany
1 shared publicationChristopher I. Li
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
1 shared publication
Latest Publications
- Open Access
- 16 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7633
ROSIE: AI generation of multiplex immunofluorescence staining from histopathology images
Hematoxylin and eosin (H&E) is a common and inexpensive histopathology assay. Though widely used and information-rich, it cannot directly inform about specific molecular markers, which require additional experiments to assess. To address this gap, we present ROSIE, a deep-learning framework that computationally imputes the expression and localization of dozens of proteins from H&E images. Our model is trained on a dataset of over 1300 paired and aligned H&E and multiplex immunofluorescence (mIF) samples from over a dozen tissues and disease conditions, spanning over 16 million cells. Validation of our in silico mIF staining method on held-out H&E samples demonstrates that the predicted biomarkers are effective in identifying cell phenotypes, particularly distinguishing lymphocytes such as B cells and T cells, which are not readily discernible with H&E staining alone. Additionally, ROSIE facilitates the robust identification of stromal and epithelial microenvironments and immune cell subtypes like tumor-infiltrating lymphocytes (TILs), which are important for understanding tumor-immune interactions and can help inform treatment strategies in cancer research.
- 16 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7633
Open AccessROSIE: AI generation of multiplex immunofluorescence staining from histopathology images
Hematoxylin and eosin (H&E) is a common and inexpensive histopathology assay. Though widely used and information-rich, it cannot directly inform about specific molecular markers, which require additional experiments to assess. To address this gap, we present ROSIE, a deep-learning framework that computationally imputes the expression and localization of dozens of proteins from H&E images. Our model is trained on a dataset of over 1300 paired and aligned H&E and multiplex immunofluorescence (mIF) samples from over a dozen tissues and disease conditions, spanning over 16 million cells. Validation of our in silico mIF staining method on held-out H&E samples demonstrates that the predicted biomarkers are effective in identifying cell phenotypes, particularly distinguishing lymphocytes such as B cells and T cells, which are not readily discernible with H&E staining alone. Additionally, ROSIE facilitates the robust identification of stromal and epithelial microenvironments and immune cell subtypes like tumor-infiltrating lymphocytes (TILs), which are important for understanding tumor-immune interactions and can help inform treatment strategies in cancer research.